Rapid desensitization and rush immunotherapy to trastuzumab (Herceptin)

Trastuzumab therapy has been shown to improve survival and to cause tumor regression in selected patients with metastatic breast cancer. 1 Severe hypersensitivity reactions, including respiratory distress, angioedema, and anaphylactoid symptoms, has been reported in 2.5 % of patients treated with tr...

Ausführliche Beschreibung